Status:
WITHDRAWN
Study to Assess Adverse Events When Subcutaneous Risankizumab Injection is Given to Adult Participants With Psoriasis in Real World Setting
Lead Sponsor:
AbbVie
Conditions:
Psoriasis
Eligibility:
All Genders
18+ years
Brief Summary
Study is not recruiting and using secondary data sources only
Detailed Description
Study is not recruiting and using secondary data sources only
Eligibility Criteria
Inclusion
- Study is not recruiting and using secondary data sources only
Exclusion
Key Trial Info
Start Date :
June 23 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 10 2022
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04799990
Start Date
June 23 2021
End Date
March 10 2022
Last Update
December 9 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.